Home NDC 63187-579 ESZOPICLONE
Product NDC 63187-579
11-digit product format 631870579
Labeler code 63187
Product ID 63187-579_a923089b-eeab-4a61-876f-9e77b896e719
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ESZOPICLONE
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Proficient Rx LP
Application ANDA091113
Marketing category ANDA
Marketing start 2014-09-25
Marketing end 0000-00-00
Substance ESZOPICLONE
Active strength 1 mg/1
DEA schedule CIV
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 8 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63187-579-30 d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63187-579-90 d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 63187-579-60 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63187-579-30 f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63187-579-90 f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 63187-579-60 f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091113-001 ESZOPICLONE ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 A091113-002 ESZOPICLONE ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 A091113-003 ESZOPICLONE ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091113-002 ESZOPICLONE 2MG TABLET / ORAL AB 2014-06-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091113-003 ESZOPICLONE 3MG TABLET / ORAL AB 2014-06-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091113-001 ESZOPICLONE 1MG TABLET / ORAL AB 2014-06-10 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ESZOPICLONE ACTIVE INGREDIENT UZX80K71OE ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 ESZOPICLONE ACTIVE MOIETY UZX80K71OE ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63187-579 ESZOPICLONE TABLET, FILM COATED [PROFICIENT RX LP] 3 Legacy NDC 20191121_0a3441ae-9831-48e8-9444-510c9e7d226b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63187-579-30 63187057930 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63187-579-30) 2018-12-01 0000-00-00 No No Current 63187-579-60 63187057960 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63187-579-60) 2018-12-01 0000-00-00 No No Current 63187-579-90 63187057990 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (63187-579-90) 2018-12-01 0000-00-00 No No Current